Lunai Bioworks Inc. LNAI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 98.00% | -91.45% | 0.53% | -6.09% | -101.31% |
| Total Depreciation and Amortization | -54.69% | -39.66% | -6.83% | 8.82% | 5.91% |
| Total Amortization of Deferred Charges | 259.69% | -8.32% | -76.43% | -93.86% | -94.49% |
| Total Other Non-Cash Items | -102.22% | 137.76% | 9.67% | 15.88% | 141.55% |
| Change in Net Operating Assets | -70.27% | -58.90% | -61.10% | -52.55% | -33.50% |
| Cash from Operations | 32.84% | 37.97% | 40.57% | 29.41% | 28.23% |
| Capital Expenditure | -- | 94.92% | 95.85% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 208.94% | 201.00% | 124.56% | 122.60% | 60.18% |
| Cash from Investing | 208.70% | 199.35% | 130.00% | 122.10% | 60.32% |
| Total Debt Issued | -66.71% | -7.16% | -15.31% | 13.19% | -13.27% |
| Total Debt Repaid | -78.08% | -100.04% | 6.95% | -12.36% | -11.62% |
| Issuance of Common Stock | -86.05% | -86.05% | 11.07% | -4.60% | 60.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.76% | -42.13% | -37.75% | -22.90% | -20.30% |
| Foreign Exchange rate Adjustments | 81.10% | -191.96% | -285.06% | -203.09% | -325.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,368.31% | 265.75% | 165.19% | 233.44% | 92.27% |